Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL
18h agoen
From the article
Conditions : CADASIL Interventions : Drug: Edaravone Dexborneol Sublingual Tablets Sponsors : Huashan Hospital; Jiangsu Simcere Pharmaceutical Co., Ltd. Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read

Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study
This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosu

Las semillas comestibles ganan protagonismo en la prevención de enfermedades crónicas
Infobae·4d ago
Phase 3 trials show orexin agonist oveporexton improves cognition, sleep, and daily function in narcolepsy type 1
Phase 3 clinical trials show that the investigational drug oveporexton (TAK-861), an oral orexin receptor 2 agonist developed by Takeda, imp
OTARMENI™ (lunsotogene parvec-cwha) suspension, for intracochlear infusion

Un nuevo estudio Relaciona mayor vitamina C con mejor salud cerebral en adultos mayores
Infobae·4d ago

Monash University study finds copper-delivering drug Cu(ATSM) reduces Alzheimer's proteins and improves memory in lab tests
Monash University researchers have discovered that a copper-delivering drug called Cu(ATSM) significantly reduces toxic Alzheimer's proteins

Comments
Sign in to join the conversation.
No comments yet. Be the first.